APA (7th ed.) Citation

Aslan, A. T., Demir, M., Tanriverdi, E. S., Permana, B., Izuagbe, R., Ramsay, K. A., . . . Hazirolan, G. Loss of OmpK35 and Glycine-aspartic acid Duplication in ompK36 Negatively Affect the in vitro Synergy of Meropenem in Combination with Piperacillin/tazobactam or Imipenem Against OXA-48-like Carbapenemase-producing Klebsiella pneumoniae. Elsevier.

Chicago Style (17th ed.) Citation

Aslan, Abdullah Tarik, et al. Loss of OmpK35 and Glycine-aspartic Acid Duplication in OmpK36 Negatively Affect the in Vitro Synergy of Meropenem in Combination with Piperacillin/tazobactam or Imipenem Against OXA-48-like Carbapenemase-producing Klebsiella Pneumoniae. Elsevier.

MLA (9th ed.) Citation

Aslan, Abdullah Tarik, et al. Loss of OmpK35 and Glycine-aspartic Acid Duplication in OmpK36 Negatively Affect the in Vitro Synergy of Meropenem in Combination with Piperacillin/tazobactam or Imipenem Against OXA-48-like Carbapenemase-producing Klebsiella Pneumoniae. Elsevier.